These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2994376)

  • 21. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
    Barth A; Craig PH; Silverstein MJ
    Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
    Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
    Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear DNA content and prognosis in human breast cancer: a static cytophotometric study.
    Harvey J; de Klerk N; Berryman I; Sterrett G; Byrne M; Papadimitriou J
    Breast Cancer Res Treat; 1987; 9(2):101-9. PubMed ID: 3304476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of supraclavicular lymph node metastasis in breast carcinoma.
    Chen SC; Chen MF; Hwang TL; Chao TC; Lo YF; Hsueh S; Chang JT; Leung WM
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):614-9. PubMed ID: 11849781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery].
    Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761
    [No Abstract]   [Full Text] [Related]  

  • 26. Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?
    Keyhani-Rofagha S; O'Toole RV; Farrar WB; Sickle-Santanello B; DeCenzo J; Young D
    Cancer; 1990 Apr; 65(7):1577-82. PubMed ID: 2311069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of quantitative cytometry in a series of 415 T1T2/N0N1/M0 breast cancer patients--preliminary results.
    Bolla M; Seigneurin D; Winckel P; Marron-Charrière J; Panh MH; Pasquier D; Ch-edin M; Payan R; Merlin F; Colonna M
    Eur J Cancer; 1996 Sep; 32A(10):1680-5. PubMed ID: 8983274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA ploidy of human breast cancer.
    Del Bino G; Silvestrini R; Zucconi MR; Marchese G; Valentinis B; Di Fronzo G; Andreola S
    Anal Cell Pathol; 1989 Aug; 1(4):215-23. PubMed ID: 2487046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumour aneuploidy, prognostic parameters and survival in primary breast cancer.
    Owainati AA; Robins RA; Hinton C; Ellis IO; Dowle CS; Ferry B; Elston CW; Blamey RW; Baldwin RW
    Br J Cancer; 1987 Apr; 55(4):449-54. PubMed ID: 3580268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practical breast carcinoma cell kinetics: review and update.
    Meyer JS; McDivitt RW; Stone KR; Prey MU; Bauer WC
    Breast Cancer Res Treat; 1984; 4(2):79-88. PubMed ID: 6378283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of DNA content using a flow cytometry method and steroid hormone receptors in breast cancer].
    Zubrikhina GN; Kuz'mina EV; Bassalyk LS; Murav'eva NI
    Vopr Onkol; 1989; 35(10):1179-86. PubMed ID: 2596061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship of estrogen receptor status to DNA ploidy in breast cancer.
    Tsuchiya A; Nihei M; Ando Y; Suzuki S; Kimijima I; Abe R
    Surg Today; 1992; 22(2):105-9. PubMed ID: 1498488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assay of DNA content and estrogen receptor status in human breast cancer].
    Chen GJ; Shao YF; Shan Y
    Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):461-4. PubMed ID: 7720507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of age on the DNA ploidy levels of breast tumours.
    Taylor IW; Musgrove EA; Friedlander ML; Foo MS; Hedley DW
    Eur J Cancer Clin Oncol; 1983 May; 19(5):623-8. PubMed ID: 6683634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
    Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
    Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometric analysis of primary tumors and their corresponding metastatic nodes in breast cancer.
    Kang HS; Youn YK; Oh SK; Choe KJ; Noh DY
    Breast Cancer Res Treat; 2000 Sep; 63(1):81-7. PubMed ID: 11079162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occult breast carcinoma presenting with axillary lymph node metastases: a follow-up study of 48 patients.
    Rosen PP; Kimmel M
    Hum Pathol; 1990 May; 21(5):518-23. PubMed ID: 2338331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.
    Fisher BJ; Perera FE; Cooke AL; Opeitum A; Venkatesan V; Dar AR; Stitt L
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):541-50. PubMed ID: 9231678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The correlation between the spread of metastases by level in the axillary nodes and disease-free survival in breast cancer. A multifactorial analysis.
    Gaglia P; Bussone R; Caldarola B; Lai M; Jayme A; Caldarola L
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):849-54. PubMed ID: 3653201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.